Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04558125).
- Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Low-Level Laser Therapy for Prevention of Oral Mucositis: Complete Statistical AnalysisIndependent statistical analysis of Low-Level Laser Therapy for Prevention of Oral Mucositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02682992).
- Low-Level Laser Therapy for Prevention of Oral Mucositis: Complete Statistical AnalysisIndependent statistical analysis of Low-Level Laser Therapy for Prevention of Oral Mucositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02723604).
- LowCostomy: Dedicated Toward Creating a High-quality, Low-cost Colostomy Appliance for Those in Sub-Saharan Africa: Complete Statistical AnalysisIndependent statistical analysis of LowCostomy: Dedicated Toward Creating a High-quality, Low-cost Colostomy Appliance for Those in Sub-Saharan Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LOWR-4Independent statistical analysis of Titrating-Dose of Lonafarnib in Combination With Ritonavir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02527707).
- LOYALIndependent statistical analysis of Latin American Real-world Study in Acute Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05166135).
- LPB Hip ScopeIndependent statistical analysis of Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LPS-FluenzIndependent statistical analysis of The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LRTforDME+PRPIndependent statistical analysis of Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00445003).
- LRTI vs Internal Brace for CMC OA: Complete Statistical AnalysisIndependent statistical analysis of LRTI vs Internal Brace for CMC OA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03971188).
- LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LSFG-SKIN, Laser Speckle Flowgraphy: Complete Statistical AnalysisIndependent statistical analysis of LSFG-SKIN, Laser Speckle Flowgraphy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03660618).
- LSPI-2Independent statistical analysis of Phase IIa L-serine Trial for eAD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03062449).
- LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers: Complete Statistical AnalysisIndependent statistical analysis of LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- LT Vaccine Patch Self-Administration Study: Complete Statistical AnalysisIndependent statistical analysis of LT Vaccine Patch Self-Administration Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00565461).
- LTBIIndependent statistical analysis of Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00804713).
- LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04): Complete Statistical AnalysisIndependent statistical analysis of LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation: Complete Statistical AnalysisIndependent statistical analysis of Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LUCENT 2Independent statistical analysis of A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Lucerno deviceIndependent statistical analysis of Patterns and Prevalence of FDG Extravasation in PET/CT Scans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03041090).
- Lucica ® Glycated Albumin-L Clinical Program – Pivotal Study: Complete Statistical AnalysisIndependent statistical analysis of Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02489773).
- LUDICASIndependent statistical analysis of Characteristics of Sexual Dysfunction in Patients With Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06018376).
- Lumbar Drain After Endoscopic Surgery of the Skull Base: Complete Statistical AnalysisIndependent statistical analysis of Lumbar Drain After Endoscopic Surgery of the Skull Base: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03163134).
- Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement: Complete Statistical AnalysisIndependent statistical analysis of Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LUME-Lung 1Complete statistical analysis of LUME-Lung 1, the phase 3 randomized trial of BIBF 1120 plus docetaxel versus placebo plus docetaxel in second-line non-small cell lung cancer, including time-to-event, response, disease-control, quality-of-life, and…
- LUMINIzEIndependent statistical analysis of Feasibility Study on the VERAFEYE System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05931835).
- LUNA 3Independent statistical analysis of Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- LUNARIndependent statistical analysis of Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with…
- Lundbeck TOMs Orthostatic Hypotension: Complete Statistical AnalysisIndependent statistical analysis of Lundbeck TOMs Orthostatic Hypotension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04510922).
- Lung Cancer Screening Eligibility Assessment: Complete Statistical AnalysisIndependent statistical analysis of Lung Cancer Screening Eligibility Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06133816).
- Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer: primary endpoint results, effect estimate with confidence…
- lungVITALIndependent statistical analysis of LungVITamin D and OmegA-3 Trial (lungVITAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01728571).
- Lurasidone – A 24-week Extension Study of Patients With Bipolar I Depression: Complete Statistical AnalysisIndependent statistical analysis of Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Lurasidone Pediatric Autism Study: Complete Statistical AnalysisIndependent statistical analysis of Lurasidone Pediatric Autism Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01911442).
- Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LUSiPDIndependent statistical analysis of Lung Ultrasound in PD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03801044).
- Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts: Complete Statistical AnalysisIndependent statistical analysis of Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts: primary endpoint results, effect estimate with confidence…
- Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L]): Complete Statistical AnalysisIndependent statistical analysis of Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [
- LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures: Complete Statistical AnalysisIndependent statistical analysis of LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib: Complete Statistical AnalysisIndependent statistical analysis of LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing…
- LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator’s Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib: Complete Statistical AnalysisIndependent statistical analysis of LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib: primary endpoint…
- LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung: Complete Statistical AnalysisIndependent statistical analysis of LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung: primary endpoint results, effect estimate…
- LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy:…